Oncology Drug Market : Global Industry Analysis and Forecast (2022-2029)

Oncology Drug Market size is expected to reach US$ 280.73 Bn. by year 2029 at a CAGR of 11.4% during the forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. Oncology Drug MarketTo know about the Research Methodology:-Request Free Sample Report

Oncology Drug Market Dynamics:

Global Oncology Drug Market is segmented on the basis of Therapeutic Modalities, Cancer types, and Geography. The increasing demand of biological and targeted drug therapies, the rising prevalence of various types of cancer, rising impact of biosimilars, and continuous patent expiry of key cancer drugs are the major factors driving the growth of Global Oncology Drug Market. However, the adverse effects of cancer drug therapy and a threat of failure, and the high cost of drug development are the key restraining factors for market growth.

Oncology Drug Market Regional Analysis:

Owing to the high efficacy of the drug based on monoclonal antibodies have gained attention in recent years, which is expected to further furl the growth of the market. Initiatives were taken by USFDA and European Union to fuel the growth of the global oncology drug market by offering pre-market approval for potential drugs under clinical development. North America is anticipated to dominate the overall oncology drug market, owing to the large presence of companies engaged in the development of cancer drugs. Europe is the second largest revenue generating region for global oncology drug market. The objective of the report is to present comprehensive assessment projections with a suitable set of assumptions and methodology. The report helps in understanding Global Oncology Drug Market dynamics, structure by identifying and analyzing the market segments and projecting the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, growth strategies, and regional presence. To understand the market dynamics and by region, the report has covered the PEST analysis by region and key economies across the globe, which are supposed to have an impact on market in forecast period. PORTER’s analysis, and SVOR analysis of the market as well as detailed SWOT analysis of key players has been done to analyze their strategies. The report will to address all questions of shareholders to prioritize the efforts and investment in the near future to the emerging segment in the Global Oncology Drug Market.

Oncology Drug Market Research Methodology:

The research methodology used in Global Oncology Drug Market report contains various secondary sources including directories such as a study of company websites, stock analysis presentation, national and international database, annual reports and press releases. Bloomberg, Hoovers, and Factiva are some of the sites that are being referred to gain insights about Automotive Temperature Sensor market. Experts from top manufacturing companies along with other stakeholders have been considered. This is done to validate and collect critical information for evaluating trends related to this market during the forecast period. Top-down and bottom-up approaches have been used to estimate the global and regional size of Global Oncology Drug Market. Data triangulation techniques along with other comparative analysis are also used to calculate the exact size of the Global Oncology drug market globally.

Oncology Drug Market, Key Highlights:

• Global Oncology drug market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Oncology drug market • Global Oncology drug market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Global Oncology drug market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Global Oncology drug market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Oncology drug market are also profiled.

Years that have been considered for the study are as follows:

• Base Year - 2021 • Estimated Year - 2022 • Forecast Period - 2022 to 2029 For company profiles, 2021 has been considered as the base year. In cases, wherein information was unavailable for the base year, the years prior to it have been considered

Oncology Drug Market Research Methodology:

The research methodology used in Global Oncology Drug Market report contains various secondary sources including directories such as a study of company websites, stock analysis presentation, national and international database, annual reports and press releases. Bloomberg, Hoovers, and Factiva are some of the sites that are being referred to gain insights about Automotive Temperature Sensor market. Experts from top manufacturing companies along with other stakeholders have been considered. This is done to validate and collect critical information for evaluating trends related to this market during the forecast period. Top-down and bottom-up approaches have been used to estimate the global and regional size of Global Oncology Drug Market. Data triangulation techniques along with other comparative analysis are also used to calculate the exact size of the Global Oncology drug market globally.

Oncology Drug Market Key Target Audience:

• Pharmaceutical and Biotechnological Companies • Venture Capitalists and Investors • Medical Research Laboratories • Hospitals and clinics • Research and Development Organizations • Business Research and Consulting Service providers • Drug Manufacturers and suppliers • Academic Research Institutes • Academic Medical Centers and universities • Government and regulatory authorities Research report categorizes the Global Oncology Drug Market based on Therapeutic Modalities, Cancer Types, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Oncology Drug market with key developments in companies and market trends.

Oncology Drug Market Scope : Inquire before buying

Global Oncology Drug Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 118.36 Bn.
Forecast Period 2022 to 2029 CAGR: 11.4% Market Size in 2029: US $ 280.73 Bn.
Segments Covered: by Therapeutic Modalities • Chemotherapy • Targeted Therapy • Immunotherapy • Hormonal
by Cancer Typ • Blood Cancer • Breast Cancer • Gastrointestinal Cancer • Prostate • Skin Cancer • Respiratory

Oncology drug Market, By Geography:

• North America • Europe • Asia Pacific • Middle East & Africa • Latin America

Oncology Drug Market, Key Players

Pfizer • Merck and company • Novartis • Glaxo Smith Kline PLC • Johnson and Johnson • Amgen • Roche Diagnostics • Eli Lilly and company • Celgene Corporation • Sanofi • F. Hoffmann-La Roche AG • Bristol-Myers Squibb Company • AbbVie Inc. • Adcock Ingram • AdoRx Therapeutics • AID Genomics Limited • Apikos Pharma • AQVIDA GmbH • Arlak Biotech • Aspen • Astellas Pharma Inc • AstraZeneca plc • Bayer AG • BeiGene • CARsgen Therapeutics

Frequently Asked Questions:

1. Which region has the largest share in Global Oncology Drug Market? Ans: Asia Pacific region holds the highest share in 2021. 2. What is the growth rate of Global Oncology Drug Market? Ans: The Global Oncology Drug Market is growing at a CAGR of 11.4% during forecasting period 2022-2029. 3. What is scope of the Global Oncology Drug market report? Ans: Global Oncology Drug Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Oncology Drug market? Ans: The important key players in the Global Oncology Drug Market are – Pfizer, Merck and company, Novartis, Glaxo Smith Kline PLC, Johnson and Johnson, Amgen, Roche Diagnostics, Eli Lilly and company, Celgene Corporation, Sanofi, F. Hoffmann-La Roche AG, and Bristol-Myers Squibb Company. 5. What is the study period of this market? Ans: The Global Oncology Drug Market is studied from 2021 to 2029.
1. Global Oncology Drug Market: Research Methodology 2. Global Oncology Drug Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Oncology Drug Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Oncology Drug Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Oncology Drug Market Segmentation 4.1 Global Oncology Drug Market, by Therapeutic Modalities (2021-2029) • Chemotherapy • Targeted Therapy • Immunotherapy • Hormonal 4.2 Global Oncology Drug Market, by Cancer Type (2021-2029) • Blood Cancer • Breast Cancer • Gastrointestinal Cancer • Prostate • Skin Cancer 5. North America Oncology Drug Market(2021-2029) 5.1 North American Oncology Drug Market, by Therapeutic Modalities (2021-2029) • Chemotherapy • Targeted Therapy • Immunotherapy • Hormonal 5.2 North America Oncology Drug Market, by Cancer Type (2021-2029) • Blood Cancer • Breast Cancer • Gastrointestinal Cancer • Prostate • Skin Cancer 5.3 North America Oncology Drug Market, by Country (2021-2029) • United States • Canada • Mexico 6. Asia Pacific Oncology Drug Market (2021-2029) 6.1. Asia Pacific Oncology Drug Market, by Therapeutic Modalities (2021-2029) 6.2. Asia Pacific Oncology Drug Market, by Cancer Type (2021-2029) 6.2. Asia Pacific Oncology Drug Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Oncology Drug Market (2021-2029) 7.1. Middle East and Africa Oncology Drug Market, by Therapeutic Modalities (2021-2029) 7.2. Middle East and Africa Oncology Drug Market, by Cancer Type (2021-2029) 7.3. Middle East and Africa Oncology Drug Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Oncology Drug Market (2021-2029) 8.1. Latin America Oncology Drug Market, by Therapeutic Modalities (2021-2029) 8.2. Latin America Oncology Drug Market, by Cancer Type (2021-2029) 8.3 Latin America Oncology Drug Market, by Country (2021-2029) • Brazil • Argentina • Rest Of Latin America 9. European Oncology Drug Market (2021-2029) 9.1. European Oncology Drug Market, by Therapeutic Modalities (2021-2029) 9.2. European Oncology Drug Market, by Cancer Type (2021-2029) 9.3 European Oncology Drug Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. Pfizer. 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Merck and company 10.3. Novartis 10.4. Glaxo Smith Kline PLC 10.5. Johnson and Johnson 10.6. Amgen 10.7. Roche Diagnostics 10.8. Eli Lilly and company 10.9. Celgene Corporation 10.10. Sanofi 10.11. F. Hoffmann-La Roche AG 10.12. Bristol-Myers Squibb Company 10.13. AbbVie Inc. 10.14. Adcock Ingram 10.15. AdoRx Therapeutics 10.16. AID Genomics Limited 10.17. Apikos Pharma 10.18. AQVIDA GmbH 10.19. Arlak Biotech 10.20. Aspen 10.21. Astellas Pharma Inc 10.22. AstraZeneca plc 10.23. Bayer AG 10.24. BeiGene 10.25. CARsgen Therapeutics

About This Report

Report ID 3372
Category Life Science
Published Date Sep 2022
Updated Date
Contact Us